343 related articles for article (PubMed ID: 22294245)
1. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?
Aucott JN; Rebman AW; Crowder LA; Kortte KB
Qual Life Res; 2013 Feb; 22(1):75-84. PubMed ID: 22294245
[TBL] [Abstract][Full Text] [Related]
2. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
[TBL] [Abstract][Full Text] [Related]
3. Development of a foundation for a case definition of post-treatment Lyme disease syndrome.
Aucott JN; Crowder LA; Kortte KB
Int J Infect Dis; 2013 Jun; 17(6):e443-9. PubMed ID: 23462300
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure.
Nilsson K; Skoog E; Jones V; Labbé Sandelin L; Björling C; Fridenström E; Edvinsson M; Mårtensson A; Olsen B
PLoS One; 2021; 16(3):e0247384. PubMed ID: 33735220
[TBL] [Abstract][Full Text] [Related]
5. Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.
Weinstein ER; Rebman AW; Aucott JN; Johnson-Greene D; Bechtold KT
Sleep; 2018 May; 41(5):. PubMed ID: 29452400
[TBL] [Abstract][Full Text] [Related]
6. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.
Rebman AW; Bechtold KT; Yang T; Mihm EA; Soloski MJ; Novak CB; Aucott JN
Front Med (Lausanne); 2017; 4():224. PubMed ID: 29312942
[TBL] [Abstract][Full Text] [Related]
7. Posttreatment Lyme disease syndrome.
Aucott JN
Infect Dis Clin North Am; 2015 Jun; 29(2):309-23. PubMed ID: 25999226
[TBL] [Abstract][Full Text] [Related]
8. Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
Nemeth J; Bernasconi E; Heininger U; Abbas M; Nadal D; Strahm C; Erb S; Zimmerli S; Furrer H; Delaloye J; Kuntzer T; Altpeter E; Sturzenegger M; Weber R; For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology
Swiss Med Wkly; 2016; 146():w14353. PubMed ID: 27922168
[TBL] [Abstract][Full Text] [Related]
9. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.
Weitzner E; McKenna D; Nowakowski J; Scavarda C; Dornbush R; Bittker S; Cooper D; Nadelman RB; Visintainer P; Schwartz I; Wormser GP
Clin Infect Dis; 2015 Dec; 61(12):1800-6. PubMed ID: 26385994
[TBL] [Abstract][Full Text] [Related]
10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
11. The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium.
Geebelen L; Lernout T; Kabamba-Mukadi B; Saegeman V; Sprong H; Van Gucht S; Beutels P; Speybroeck N; Tersago K
Arch Public Health; 2017; 75():42. PubMed ID: 28794875
[TBL] [Abstract][Full Text] [Related]
12. CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.
Aucott JN; Soloski MJ; Rebman AW; Crowder LA; Lahey LJ; Wagner CA; Robinson WH; Bechtold KT
Clin Vaccine Immunol; 2016 Sep; 23(9):757-66. PubMed ID: 27358211
[TBL] [Abstract][Full Text] [Related]
13. Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months.
Wormser GP; McKenna D; Karmen CL; Shaffer KD; Silverman JH; Nowakowski J; Scavarda C; Shapiro ED; Visintainer P
Clin Infect Dis; 2020 Dec; 71(12):3118-3124. PubMed ID: 31996890
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
Vrijmoeth HD; Ursinus J; Harms MG; Zomer TP; Gauw SA; Tulen AD; Kremer K; Sprong H; Knoop H; Vermeeren YM; van Kooten B; Joosten LAB; Kullberg BJ; Hovius JWR; van den Wijngaard CC
BMC Infect Dis; 2019 Apr; 19(1):324. PubMed ID: 30987580
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and 1-year follow-up of patients presenting at a Lyme borreliosis expertise centre: a prospective cohort study with validated questionnaires.
van de Schoor FR; Baarsma ME; Gauw SA; Ursinus J; Vrijmoeth HD; Ter Hofstede HJM; Tulen AD; Harms MG; Wong A; van den Wijngaard CC; Joosten LAB; Hovius JW; Kullberg BJ
Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):937-946. PubMed ID: 38492058
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second Edition.
Wormser GP; Park K; Madison C; Rozenberg J; McKenna D; Scavarda C; Karmen C; Dornbush R; Visintainer P
Am J Med; 2019 Apr; 132(4):519-524. PubMed ID: 30562495
[TBL] [Abstract][Full Text] [Related]
17. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.
Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ
EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992
[TBL] [Abstract][Full Text] [Related]
18. Treatment of post-treatment Lyme disease symptoms-a systematic review.
Dersch R; Torbahn G; Rauer S
Eur J Neurol; 2024 Jul; 31(7):e16293. PubMed ID: 38606630
[TBL] [Abstract][Full Text] [Related]
19. Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.
Bechtold KT; Rebman AW; Crowder LA; Johnson-Greene D; Aucott JN
Arch Clin Neuropsychol; 2017 Mar; 32(2):129-141. PubMed ID: 28365751
[TBL] [Abstract][Full Text] [Related]
20. A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
Morrissette M; Pitt N; González A; Strandwitz P; Caboni M; Rebman AW; Knight R; D'Onofrio A; Aucott JN; Soloski MJ; Lewis K
mBio; 2020 Sep; 11(5):. PubMed ID: 32994327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
